Anixa Biosciences Inc Quarterly Operating Lease, Right-of-Use Asset in USD from Q3 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Anixa Biosciences Inc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q3 2019 to Q2 2024.
  • Anixa Biosciences Inc Operating Lease, Right-of-Use Asset for the quarter ending July 31, 2024 was $238K, a 33.7% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $238K +$60K +33.7% Jul 31, 2024 10-Q 2024-09-06
Q1 2024 $141K -$48K -25.4% Apr 30, 2024 10-Q 2024-06-04
Q4 2023 $153K -$48K -23.9% Jan 31, 2024 10-Q 2024-03-12
Q3 2023 $166K -$46K -21.7% Oct 31, 2023 10-Q 2024-09-06
Q2 2023 $178K -$45K -20.2% Jul 31, 2023 10-Q 2023-09-06
Q1 2023 $189K -$45K -19.2% Apr 30, 2023 10-Q 2023-06-14
Q4 2022 $201K -$43K -17.6% Jan 31, 2023 10-Q 2023-03-17
Q3 2022 $212K -$42K -16.5% Oct 31, 2022 10-K 2024-01-16
Q2 2022 $223K +$213K +2042% Jul 31, 2022 10-Q 2022-09-09
Q1 2022 $234K +$208K +815% Apr 30, 2022 10-Q 2022-06-10
Q4 2021 $244K +$204K +507% Jan 31, 2022 10-Q 2022-03-11
Q3 2021 $254K +$200K +367% Oct 31, 2021 10-K 2023-01-04
Q2 2021 $10.4K -$57.6K -84.7% Jul 31, 2021 10-Q 2021-09-01
Q1 2021 $25.6K -$55.6K -68.5% Apr 30, 2021 10-Q 2021-06-10
Q4 2020 $40.2K -$53.7K -57.2% Jan 31, 2021 10-Q 2021-03-11
Q3 2020 $54.3K -$51.9K -48.8% Oct 31, 2020 10-K 2022-01-04
Q2 2020 $68K Jul 31, 2020 10-Q 2020-09-08
Q1 2020 $81.2K Apr 30, 2020 10-Q 2020-06-09
Q4 2019 $93.9K Jan 31, 2020 10-Q 2020-03-09
Q3 2019 $106K Nov 1, 2019 10-Q 2020-06-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.